The combination of selected fibrinolytic and coaguAbstract lation measurements is useful for the detection of a hypercoagulable state in conditions characterHypercoagulable states can be detected by meaized by a risk of thrombosis. © 1999 Elsevier Scisuring activation peptides, enzyme-inhibitor comence Ltd. All rights reserved. plexes, and fibrin/fibrinogen degradation products, which are markers of hemostatic activation. A series of these prethrombotic markers has been eval-
uated in the elderly, pregnancy, diabetes and acute myocardial infarction patients (nϭ30 in each group) as well as in hematologic malignancies (nϭ42). The A prethrombotic state may be defined as a parameters assayed were: prothrombin fragment condition characterized by an imbalance 1ϩ2 (F1ϩ2), thrombin-antithrombin III complexes in hemostasis with a tendency to hyper-(TAT), fibrinopeptide A (FPA), plasmin-␣ 2 anticoagulability, due to pathological activation of the plasmin complexes (PAP) and D-Dimer. Results enzymes of the coagulation cascade, but without were compared with those obtained in a group of clinical signs of thrombosis or evidence of fibrin 30 healthy subjects.
deposition [1] . Hypercoagulable states can be clasWe found a significant increase of F1ϩ2, TAT sified into two broad categories: congenital and and FPA in elderly (pϽ0.05), acute myocardial acquired. The former are generally inherited abinfarction (AMI) (pϽ0.01), hematologic malignannormalities of hemostasis clearly identified, while cies (pϽ0.01), and pregnancy (pϽ0.0001), indicatacquired hypercoagulable states include clinical coning a marked clotting activation. Diabetic patients ditions associated with an increased risk of thromunder strict metabolic control only presented a modbosis in whom the exact pathophysiologic mechaerate increase of TAT (pϽ0.05), suggesting a slight nism remains unclear [2, 3] . activation. We also observed a highly significant ele-
The importance of detecting these prethromvation of PAP and D-Dimer in elderly (pϽ0.001), botic states deals with the possibility to diminish AMI (pϽ0.0001), and malignancy (pϽ0.0001), inthe thrombotic tendency by treating or eliminating dicating an activation of the fibrinolytic system. the responsible factors. Advances in our knowledge of the biochemistry of the hemostatic mechanism have allowed the development of sensitive
Abbreviations: F1ϩ2, prothrombin fragment 1ϩ2; TAT, thrombin-antithrombin complex; PAP, plasmin-antiplasmin complex;
and specific assays to detect activation of coagula- Blood samples were collected in the morning, with Previous studies analyzing the integrity of the patients at rest, in siliconized vacutainer tubes conhemostatic system in prethrombotic states do not taining 1:10 of 0.13 M trisodium citrate. Samples offer a complete perspective since, in general, only were kept on ice until centrifugation at 3000g for individual components have been assessed. The aim 15 minutes, performed within the first hour after of our study was to include a complete set of precollection. Aliquots of platelet-poor plasma were thrombotic markers in a series of clinical conditions stored at Ϫ70ЊC. characterized by a high thrombotic tendency.
1.3. Assays
Patients and Methods
Prothrombin fragment 1ϩ2 (F1ϩ2), was assayed using the commercial Enzygnost Data was statistically described using mean values, standard deviation (SD) and standard error of the myocardial infarction (AMI) were studied during the first week from the onset of diagnosis (mean mean (SEM). Values were tested for the type of distribution using Kolmogorov-Smirnov test. As ageϭ 61.3Ϯ10.6 years, male/femaleϭ18:12); all patients were receiving aspirin (250 mg/d) and hepathe parameters followed a not normal distribution the median was also assessed. Statistical analysis rin (7500 IU) subcutaneously twice daily. A group of 42 patients with hematologic malignancies were was done with the two-tail Mann-Whitney U test for comparison of median of impaired data. Correstudied during the active phase of the disease, before chemotherapy (mean ageϭ47.3Ϯ17.6 years; lations were calculated using Spearman's rank test. A value of pϽ0.05 was considered to be significant. male/femaleϭ25:17). Malignancies included: Hodgkin's disease (nϭ11), non Hodgkin's lymphoma (nϭ8), myeloma (nϭ11), and acute leukemia (nϭ12). Subjects included in the control group
Results
(mean ageϭ45.3Ϯ9.15 years; male/femaleϭ19:11) did not present any known thrombotic risk factor
The plasma levels of selected coagulation and fibrinolysis markers were measured in 162 patients, and had not taken neither anti-inflammatory nor with a variety of clinical conditions known to be 2.4. Acute Myocardial Infarction (AMI) associated with an increased thrombotic tendency.
Plasma samples from 30 patients who had suffered Individual distribution of data, according to differa myocardial infarction were drawn within a week ent patients categories, is shown in Figures 1 and after the acute episode. The levels of all clotting 2, whereas the mean values are reported in Table 1. markers were significantly elevated as compared to the control group (Table 1 and Figure 1) 
Pregnancy
Forty-two patients with different hematologic malignancies were included. As shown in Figure 1 , Thirty healthy pregnant women in the third gesthe levels of all clotting markers, mainly TAT, tational trimester were included in the study. As increased significantly in relation to controls shown in Figure 1 and Table 1 PAP levels due to the wide data dispersion. was a trend for a TAT increase (pϽ0.05), F1ϩ2 and FPA levels showed no significant differences in relation to control (Table 1) . We also found a
Discussion significant increase of PAP complexes (pϽ0.01), while the concentration of D-Dimer was within the
The assessment of prethrombotic markers may be useful to elucidate the role of clotting activation normal range (Figure 2) . and fibrinolysis impairment before the developthe hemostatic impairment in different clinical conditions characterized by an increased tendency ment of clinical thrombosis. However, previous studies on hemostasis alterations in hypercoagulato thrombosis. In view of the known association between vascuble states offer a partial view on the pathophysiological role of coagulation and fibrinolysis mechalar complications and advanced age [12,13], we have analyzed several hemostatic factors in a group nisms [reviewed in references [1] [2] [3] [4] [5] [6] . In this report, we have included a wide set of prethrombotic of apparently healthy elderly subjects. We found an activation of the coagulation system as indicated markers to have a more complete information on by the increase of F1ϩ2, TAT, and FPA. Bauer et al. demonstrated that the increased values of F1ϩ2 in elderly patients were due to excessive production and not to a diminished clearance of the fragment [14] . We also found that FPA levels correlated positively with F1ϩ2 and TAT, suggesting that thrombin formation is accompanied by an increase in fibrin generation [15] . The correlations between D-Dimer levels and clotting markers suggest that fibrinolysis could compensate for the hypercoagulable state in the elderly group.
We found a significant increase of F1ϩ2, TAT and FPA in pregnancy, indicating a marked activation of the coagulation system during the third trimester of gestation [16] . Some studies have demonstrated that the increase of TAT levels may be a marker for detecting pregnancies complicated with hypertension or pre-eclampsia [17, 18] . The observed correlations of TAT levels with F1ϩ2 and D-Dimer in our study suggest that increased thrombin formation associated with fibrin generation is also present in uncomplicated pregnancies even though PAP complexes decreased. An increase in plasminogen activator inhibitors during pregnancy [19] [20] [21] could account for a reduction in PAP complex formation.
Diabetes mellitus is often associated with microangiopathy, atherosclerosis, and an impairment of the hemostatic system [22] . We found a slight increase of TAT complexes with normal levels of F1ϩ2 and FPA in the diabetic group, indicating a moderate coagulation activation. Previous studies have suggested that the clotting impairment in diabetes depends on the presence of vascular complications and on the degree of metabolic regulation, mainly the glycemic control [23] [24] [25] . Our study supports these observations, since our patients were under strict metabolic control and had no vascular complications. On the other hand, despite the significant elevation of PAP levels, no D-Dimer increase occurred, and no correlation between both parameters could be demonstrated, suggesting that no significant amounts of fibrin have been generated.
The hemostatic mechanism is known to be activated in the acute phase of myocardial infarction [26] . In our study, a significant increase of all clotting activation markers and a positive correlation among them was present in patients who had suf- AA, Douglas AS. The effect of age upon the coagulation system. J Clin Pathol 1974;27:980-2. 14. Bauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD. Aging-associated changes
